Vaccination as a prevention strategy for human papillomavirus-related diseases

Journal of Adolescent Health

Volumn 37, Issue 6 SUPPL., 2005, Pages

  Kahn, Jessica A ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

HPV; Public health; Vaccinations

Indexed keywords

VIRUS VACCINE;

CLINICAL TRIAL; CONDYLOMA; GENETIC ANALYSIS; HEALTH PROGRAM; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; UTERINE CERVIX CARCINOMA; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIALS; VIRAL VACCINES;

EID: 27944435685     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2005.08.018     Document Type: Review

References (44)

1. D.R. Brown, M.L. Shew, B. Qadadri A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women J Infect Dis 191 2005 182 192
2. J.A. Kahn, P.A. Hillard Human papillomavirus and cervical cytology in adolescents Adolesc Med Clin 15 2004 301 321
3. F.X. Bosch, A. Lorincz, N. Munoz The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 2002 244 265
4. M.L. Gillison, D.R. Lowy A causal role for human papillomavirus in head and neck cancer Lancet 363 2004 1488 1489
5. P.E. Castle, M. Schiffman, M.C. Bratti A population-based study of vaginal human papillomavirus infection in hysterectomized women J Infect Dis 190 2004 458 467
6. J.R. Daling, M.M. Madeleine, L.G. Johnson Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer Cancer 101 2004 270 280
7. K.R. Beutner, M.V. Reitano, G.A. Richwald AMA Expert Panel on External Genital Warts External genital warts report of the American Medical Association Consensus Conference Clin Infect Dis 27 1998 796 806
8. M.Y. Tjiong, T.A. Out, J. Ter Schegget Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical carcinoma in the lower female genital tract a review Int J Gynecol Cancer 11 2001 9 17
9. N. Munoz, F.X. Bosch, S. de Sanjose Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527
10. W.F. Bergler, K. Gotte Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis Eur Arch Otorhinolaryngol 257 2000 263 269
11. G. von Krogh, C.J. Lacey, G. Gross European guideline for the management of anogenital warts Int J STD AIDS 12 suppl 3 2001 40 47
12. M.J. Silverberg, P. Thorsen, H. Lindeberg Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis Obstet Gynecol 101 2003 645 652
13. K.R. Beutner, T.M. Becker, K.M. Stone Epidemiology of human papillomavirus infections Dermatol Clin 9 1991 211 218
14. L.A. Koutsky, D.A. Galloway, K.K. Holmes Epidemiology of genital human papillomavirus infection Epidemiol Rev 10 1988 122 163
15. C.L. Law, A. Merianos, J. Grace Clinical and virological associations between external anogenital warts and cervical HPV infection in an STD clinic population Int J STD AIDS 2 1991 30 36
16. J.E. Horn, G.M. McQuillan, K.V. Shah Genital human papillomavirus infections in patients attending an inner-city STD clinic Sex Transm Dis 18 1991 183 187
17. L.S. Cook, L.A. Koutsky, K.K. Holmes Clinical presentation of genital warts among circumcised and uncircumcised heterosexual men attending an urban STD clinic Genitourin Med 69 1993 262 264
18. G. Persson, L.G. Dahlof, I. Krantz Physical and psychological effects of anogenital warts on female patients Sex Transm Dis 20 1993 10 13
19. M.G. Chandler Genital warts a study of patient anxiety and information needs Br J Nurs 5 1996 174 179
20. R.P. Insinga, A.G. Glass, B.B. Rush The health care costs of cervical human papillomavirus-related disease Am J Obstet Gynecol 191 2004 114 120
21. R.P. Insinga, E.J. Dasbach, E.R. Myers The health and economic burden of genital warts in a set of private health plans in the United States Clin Infect Dis 36 2003 1397 1403
22. D.R. Lowy, I.H. Frazer Chapter 16 prophylactic human papillomavirus vaccines J Natl Cancer Inst Monogr 2003 111 116
23. J.T. Schiller, P. Davies Delivering on the promise HPV vaccines and cervical cancer Nat Rev Microbiol 2 2004 343 347
24. N.D. Christensen Emerging human papillomavirus vaccines Expert Opin Emerg Drugs 10 2005 5 19
25. P.E. Gravitt, K.V. Shah A virus-based vaccine may prevent cervical cancer Curr Infect Dis Rep 7 2005 125 131
26. M.E. Hagensee, N. Yaegashi, D.A. Galloway Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins J Virol 67 1993 315 322
27. R. Kirnbauer, J. Taub, H. Greenstone Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles J Virol 67 1993 6929 6936
28. K.H. Fife, C.M. Wheeler, L.A. Koutsky Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women Vaccine 22 2004 2943 2952
29. K.A. Ault, A.R. Giuliano, R.P. Edwards A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine Vaccine 22 2004 3004 3007
30. L.A. Koutsky, K.A. Ault, C.M. Wheeler A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 2002 1645 1651
31. D.M. Harper, E.L. Franco, C. Wheeler Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women a randomised controlled trial Lancet 364 2004 1757 1765
32. L.L. Villa, R.L.R. Costa, C.A. Petta Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L2 virus-like particle vaccine in young women a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol 6 2005 271 278 [published online April 7, 2005:D01 10.1016/S470-2045(05)70101-7]
33. M. Reinis Technology evaluation HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL Curr Opin Mol Ther 6 2004 206 211
34. Skjeldestad FE, et al. Prophylactic quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine (Gardasil™) reduces cervical intraepithelial neoplasia (CIN) 2/3 risk. Presented at: Infectious Disease Society of America 43rd Annual Meeting; October 7, 2005; San Francisco, Calif. Abstract LB-8a. Available at: http://www.idsociety.org/Template.cfm?Section=Program2&CONTENTID= 14108&TEMPLATE=/ContentManagement/ContentDisplay.cfm. Accessed November 8, 2005.
35. A.R. Hinman, W.A. Orenstein, E.A. Mortimer When, where, and how do immunizations fail? Ann Epidemiol 2 1992 805 812
36. G.D. Zimet, R.M. Mays, J.D. Fortenberry Vaccines against sexually transmitted infections promise and problems of the magic bullets for prevention and control Sex Transm Dis 27 2000 49 52
37. M.E. Hagensee, J.E. Cameron, J.E. Leigh Human papillomavirus infection and disease in HIV-infected individuals Am J Med Sci 328 2004 57 63
38. G.M. Clifford, J.S. Smith, M. Plummer Human papillomavirus types in invasive cervical cancer worldwide a meta-analysis Br J Cancer 88 2003 63 73
39. N. Munoz, F.X. Bosch, X. Castellsague Against which human papillomavirus types shall we vaccinate and screen? The international perspective Int J Cancer 111 2004 278 285
40. G.P. Garnett Role of herd immunity in determining the effect of vaccines against sexually transmitted disease J Infect Dis 191 suppl 1 2005 S97 S106
41. S.J. Goldie, M. Kohli, D. Grima Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine J Natl Cancer Inst 96 2004 604 615
42. R.M. Mays, L.A. Sturm, G.D. Zimet Parental perspectives on vaccinating children against sexually transmitted infections Soc Sci Med 58 2004 1405 1413
43. G.D. Zimet, S.M. Perkins, L.A. Sturm Predictors of STI vaccine acceptability among parents and their adolescent children J Adolesc Health 37 2005 179 186
44. E. Olshen, E.R. Woods, S.B. Austin Parental acceptance of the human papillomavirus vaccine J Adolesc Health 37 2005 248 251